MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-18-0140012
Indonova Pharmaceuticals Private Limited
Indonova Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹97.91 Lakh
▲ 41% YoY
Net profit · FY 2025
₹7.65 Lakh
Net margin 7.8%
EBITDA · FY 2025
₹10.34 Lakh
EBITDA margin 10.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
16 yrs
Est. 2010
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Indonova Pharmaceuticals Private Limited
Data last updated:
Indonova Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 July 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2010PTC205301. Its GSTIN is 27AACCI3710L1ZM (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Dsouza Precilla Gretta and Richard Jeevan Camil John Dsouza.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Building No.6A Flat No.11 Takshila Hsg Soc. Mahakali Caves Road Andheri (East), Mumbai, Maharashtra, India – 400093.
As per the financials filed for FY 2025, the company reported a revenue of ₹97.91 Lakh, a growth of 41% compared to the previous year. For the same year it recorded a net profit of ₹7.65 Lakh (net margin 7.8%) and EBITDA of ₹10.34 Lakh (EBITDA margin 10.6%). Revenue has grown at a compounded annual rate (CAGR) of 4% over five years.
Indonova Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0140012). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24233MH2010PTC205301
Registration Number 205301
Incorporation Date 06 July 2010
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-18-0140012
Key People
Dsouza Precilla Gretta Director Richard Jeevan Camil John Dsouza Director Manisha Dsouza Director Recognitions & Rankings of Indonova Pharmaceuticals
Contact details
Indonova Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBuilding No.6A Flat No.11 Takshila Hsg Soc. Mahakali Caves Road Andheri (East), Mumbai, Maharashtra, India – 400093
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Indonova Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Indonova Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Indonova Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Indonova Pharmaceuticals Private Limited, buy the company report.
Financials of Indonova Pharmaceuticals Private Limited
FY 2025 filings availableIndonova Pharmaceuticals Private Limited reported revenue of ₹97.91 Lakh (up 41% YoY) for FY 2025.
Revenue · FY 2025
₹97.91 Lakh ▲ 41%
Net profit · FY 2025
₹7.65 Lakh margin 7.8%
EBITDA · FY 2025
₹10.34 Lakh margin 10.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 41%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▼ 20%
3 years · compounded
▲ 11%
5 years · compounded
▼ 8%
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 41% growth in the latest year. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.34 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.65 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.6% | ||||
| Net Profit Margin | 7.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Indonova Pharmaceuticals Private Limited, buy the company report.
Board of directors of Indonova Pharmaceuticals Private Limited
Indonova Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dsouza Precilla Gretta | Director | 06 Jul 2010 | 16 Years 3 Months | Current |
| Richard Jeevan Camil John Dsouza | Director | 06 Jul 2010 | 16 Years 3 Months | Current |
| Manisha Dsouza | Director | 06 Jul 2010 | 16 Years 3 Months | Current |
Peer comparison
Indonova Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gosoka Pharmaceuticals Private Limited | ₹98.07 Lakh (FY 2025) | -6.0% | Mehsana, Gujarat, India | |||
| SM Drugs Private Limited | ₹97.99 Lakh (FY 2018) | -47.0% | Madurai, Tamil Nadu, India | |||
| Jagajothi Pharma Private Limited | ₹97.96 Lakh (FY 2021) | -29.0% | Aruppukottai, Tamil Nadu, India | |||
| Promeda Chemotrade Private Limited | ₹97.94 Lakh (FY 2023) | -80.0% | Mumbai, Maharashtra, India | |||
| Indonova Pharmaceuticals Private Limitedthis company | ₹97.91 Lakh (FY 2025) | ₹7.65 Lakh | 7.8% | 41.0% | Mumbai, Maharashtra, India | |
| Seamus Pharmaceuticals Private Limited | ₹97.87 Lakh (FY 2024) | 65.0% | Unnao, Uttar Pradesh, India | |||
| Marina Pharmaceuticals Private Limited | ₹97.81 Lakh (FY 2025) | 33.0% | Patna, Bihar, India |
To see the full peer comparison of Indonova Pharmaceuticals Private Limited, buy the company report.
Auditor
Indonova Pharmaceuticals Private Limited is audited by JOSEPH MENDONSA & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JOSEPH MENDONSA & CO | FY 2020 | 104352W |
Shareholding
The shareholding of Indonova Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Indonova Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Indonova Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indonova Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Indonova Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCI3710L1ZM | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Indonova Pharmaceuticals Private Limited, buy the company report.
Recent activity
Indonova Pharmaceuticals Private Limited has 3 board changes on record since 2010: 3 appointments. The latest: Dsouza Precilla Gretta was appointed as Director on 06 Jul 2010.
AGM
Indonova Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Indonova Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Dsouza Precilla Gretta was appointed as Director.
Appointed
Manisha Dsouza was appointed as Director.
Appointed
Richard Jeevan Camil John Dsouza was appointed as Director.
Incorporation
06 Jul 2010
Indonova Pharmaceuticals Private Limited was registered on 06 Jul 2010 with Roc Mumbai I & aged 16 years 3 months as per MCA records.
Frequently asked questions
Indonova Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 July 2010 (16+ years old) and is registered under CIN U24233MH2010PTC205301.
Indonova Pharmaceuticals has 3 current directors:
- Dsouza Precilla Gretta - Director
- Richard Jeevan Camil John Dsouza - Director
- Manisha Dsouza - Director
The latest financial statements of Indonova Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Indonova Pharmaceuticals is 27AACCI3710L1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Indonova Pharmaceuticals is U24233MH2010PTC205301. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indonova Pharmaceuticals was incorporated on 06 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Indonova Pharmaceuticals by revenue are Gosoka Pharmaceuticals Private Limited, SM Drugs Private Limited, Jagajothi Pharma Private Limited, Promeda Chemotrade Private Limited, Seamus Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Dsouza Precilla Gretta was appointed as Director on 06 Jul 2010. Manisha Dsouza was appointed as Director on 06 Jul 2010. Richard Jeevan Camil John Dsouza was appointed as Director on 06 Jul 2010.
Yes, Indonova Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-18-0140012).
The registered office of Indonova Pharmaceuticals is at Building No.6A Flat No.11 Takshila Hsg Soc. Mahakali Caves Road Andheri East, Mumbai, Maharashtra, India – 400093.
Indonova Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.